Professionals 39 results
Capabilities 22 results
Practice Area
Industry
Industry
Experience 1 result
Experience
|December 10, 2020
Insights & News 133 results
Product Liability & Mass Torts Digest
|September 18, 2024
|3 Min Read
Microplastics Policy: Is Federal Preemption a Viable Defense?
There are myriad examples of lawsuits ensuing after a regulatory body or other agency issues a statement or report on a particular substance. As things currently stand, however, statements by the U.S. Food and Drug Administration (FDA) may offer a defense to claims involving microplastics.
Article
|September 4, 2024
|10+ Min Read
News
|August 15, 2024
|6 Min Read
Key Takeaways From Winston’s Fourth Annual Health Care & Life Sciences Summit
Other Results 28 results
Law Glossary
Law Glossary
What Is the Standard for the FDA to Grant a Biosimilar License?
Law Glossary
What Is the Standard for the FDA to Grant a Generic Drug License?